Med Spas Offering Semaglutide: What the UK Picture Actually Looks Like

You've seen it on social media: a spa, a drip, a jab

The image is familiar by now. A sleek clinic in Miami or Los Angeles, someone posting about their "skinny jab" booked alongside a facial. In the US, compounded semaglutide (mixed in independent pharmacies and sold through med spas, gyms and wellness studios) became a multi-billion-dollar industry almost overnight. The FDA has since moved to restrict it, but the cultural echo reached the UK, and searches for semaglutide at a med spa climbed accordingly.

The situation here looks quite different. The UK has no licensing route for compounded semaglutide as a weight-loss medicine. The only legally marketable product for this purpose is Wegovy, a branded, Novo Nordisk-manufactured medicine assessed and approved by the MHRA. Any clinic presenting an alternative version as equivalent, or selling a "semaglutide treatment" that isn't sourced through the licensed UK supply chain, is not offering you the product that was tested in the clinical trials you've read about. The NHS's own guidance on semaglutide makes the distinction between authorised medicines and unlicensed alternatives clear.

This doesn't mean there's no legitimate private route. It means the route matters. A setting that looks clinical isn't the same as one that is regulated.

What the UK rules actually require of any legitimate prescriber

Because semaglutide is a Prescription-Only Medicine, the Human Medicines Regulations 2012 govern every step of its supply. A prescriber must carry out a proper clinical assessment, satisfy themselves that treatment is appropriate for this specific patient, and take clinical responsibility for the prescription. That applies whether the prescriber sits in a GP surgery, a hospital clinic, or reviews consultations for an online pharmacy.

NICE's appraisal of semaglutide for weight management, TA875, outlines the patient criteria within NHS commissioning; private prescribers follow the licensed indication in the medicine's SmPC. Either way, handing over semaglutide after a five-minute conversation about lifestyle goals, with no BMI check, no medical history review and no prescriber taking named responsibility, is not compliant. A legitimate UK provider will ask detailed questions, verify your identity and current weight, notify your GP in line with GPhC guidance, and clinically re-review before each repeat.

If a clinic or spa is vague about who the prescriber is, which pharmacy is dispensing, or how your records are handled, those are reasons to pause. You can check any online pharmacy's registration on the GPhC register in under a minute.

The counterfeit risk attached to unofficial channels

This is where the med-spa framing carries a real safety cost. The MHRA has publicly warned about fake weight-loss pens circulating online and through informal sellers, including pens that have been found to contain insulin rather than the intended medicine. Large seizures of counterfeit tirzepatide and semaglutide pens have been made across the UK; the enforcement effort is ongoing. You can report any suspect product or seller through the MHRA's Yellow Card scheme.

Price is not a reliable safety signal. A pen sold cheaply through an aesthetics clinic's back room may look identical to the licensed product; the contents are something else entirely. For a prescription medicine, the cheapest listing answers the wrong question. The right question is whether the supply chain, the prescriber and the pharmacy are all verifiable and regulated.

For context on what legitimate private treatment costs in the UK, our guide to where Wegovy is available covers the pricing landscape without dressing it up. The short version: Eli Lilly raised Mounjaro's list price substantially from September 2025, and semaglutide prices have moved in the same broader market; typical private monthly costs vary by dose and provider.

What a regulated UK prescribing service looks like instead

If the appeal of a med spa is speed, discretion and not sitting in a waiting room for three months, those things are available through a GPhC-registered online pharmacy without compromising on the clinical oversight. At nume, a named GPhC-registered Independent Prescriber reads every consultation the same day, not software, not a triage checklist, a clinician. Order before 12pm on a weekday and, once clinically approved, treatment is dispatched the same day and arrives the next working day in plain packaging.

People often ask our clinical team whether an aesthetics clinic or wellness studio they've seen advertising weight-loss injections is legitimate. The honest answer is: it depends entirely on whether they have a properly licensed prescriber, a registered pharmacy dispensing the medicine, and full clinical processes behind the glossy branding. Some do. Many don't. The GPhC register is the check that matters, not the interior design.

Wegovy is also now available as a once-daily tablet, the first oral GLP-1 medicine licensed for weight management in the UK, approved by the MHRA in June 2026. If injections aren't your preference, that option exists through a legitimate prescriber. Read more on the weight-loss treatment overview or explore how different semaglutide doses are used in the titration schedule, and you can find further detail on how semaglutide 2 fits into that progression as your dose increases. Either way, the starting point is a proper clinical assessment, not a spa booking. Check your eligibility through a free consultation with our prescribers at the treatments page.